Related Experiment Videos
Treatment of Helicobacter pylori infection in children
1Baylor College of Medicine, Texas Childrens Hospital, Feigin Center, MC 3-3391, 6621 Fannin St., Houston, Texas 77030-2399, USA. mgilger@texaschildrenshospital.org
Insights
Helicobacter pylori (H. pylori) infection in children is poorly understood, with no clear guidelines for treatment. Triple therapy is the most effective treatment option currently available for pediatric H. pylori infections.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Microbiology
Background:
- Helicobacter pylori (H. pylori) infection is common in children, but its natural history and optimal management remain unclear.
- Lack of controlled studies hinders consensus on treatment indications and regimens for pediatric H. pylori infections.
Purpose of the Study:
- To review the current understanding of H. pylori infection in children.
- To evaluate evidence for treatment indications and effective therapeutic strategies in pediatric H. pylori infections.
Main Methods:
- Literature review of studies on H. pylori infection in children.
- Analysis of evidence supporting treatment for specific pediatric conditions associated with H. pylori.
- Evaluation of the efficacy of different H. pylori eradication regimens in children.
Main Results:
- Evidence supports H. pylori treatment in children with peptic ulcer disease, gastric MALT lymphoma, and atrophic gastritis.
- Limited evidence supports treatment for asymptomatic children, those with recurrent abdominal pain, or those with a family history of H. pylori.
- Single and dual antibiotic therapies are ineffective; triple therapy (two antibiotics plus a proton pump inhibitor) for two weeks shows the most promise.
Conclusions:
- Further controlled studies are needed to establish definitive treatment guidelines for H. pylori in children.
- Triple therapy is the current recommended regimen for pediatric H. pylori eradication when treatment is indicated.
- Clearer diagnostic and therapeutic strategies are required for managing H. pylori infection in pediatric populations.
Abstract:
The majority of Helicobacter pylori (H. pylori) infections appear to be acquired during childhood. Despite this fact, the natural history of H. pylori infection in children, such as the mode of acquisition, the clinical symptoms and signs of infection and the appropriate treatment, is poorly understood. There is no consensus regarding which children with H. pylori infection deserve treatment nor is there agreement on the appropriate treatment regimen. This stems from the lack of controlled studies into H. pylori infection during childhood. For example, there have been no controlled studies to determine effective treatment of H. pylori infection in children. Although published guidelines for the treatment of childhood H. pylori infection do not currently exist, there is reasonable evidence to support treatment in children with gastric or duodenal ulcer, gastric MALT (mucosa-associated lymphoid tissue) lymphoma and atrophic gastritis. There is no strong evidence to recommend treatment of children with H. pylori infection and recurrent abdominal pain, asymptomatic infection, children in chronic care facilities and children who have a family member with H. pylori infection. Current evidence suggests that single and dual therapy regimens for H. pylori infection in children are not effective. Triple therapy , generally the combination of 2 antibiotics and a proton pump inhibitor, given two times daily for 2 weeks appears to offer the best current treatment.